210 related articles for article (PubMed ID: 38172937)
1. Association between Tobacco Industry Interference Index (TIII) and MPOWER measures and adult daily smoking prevalence rate in 30 countries.
Lee Y; Kim S; Kim MK; Kawachi I; Oh J
Global Health; 2024 Jan; 20(1):6. PubMed ID: 38172937
[TBL] [Abstract][Full Text] [Related]
2. Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014.
Levy DT; Yuan Z; Luo Y; Mays D
Tob Control; 2018 Jan; 27(1):50-57. PubMed ID: 27956650
[TBL] [Abstract][Full Text] [Related]
3. Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020.
Lyle G; Hendrie D
Global Health; 2024 May; 20(1):40. PubMed ID: 38715053
[TBL] [Abstract][Full Text] [Related]
4. An overview of tobacco control and prevention policy status in Africa.
Husain MJ; English LM; Ramanandraibe N
Prev Med; 2016 Oct; 91S():S16-S22. PubMed ID: 26876626
[TBL] [Abstract][Full Text] [Related]
5. SEATCA Tobacco Industry Interference Index: a tool for measuring implementation of WHO Framework Convention on Tobacco Control Article 5.3.
Assunta M; Dorotheo EU
Tob Control; 2016 May; 25(3):313-8. PubMed ID: 25908597
[TBL] [Abstract][Full Text] [Related]
6. Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan.
Yang SL; Togawa K; Gilmour S; Leon ME; Soerjomataram I; Katanoda K
Tob Control; 2024 Apr; 33(3):295-301. PubMed ID: 36100264
[TBL] [Abstract][Full Text] [Related]
7. The status of tobacco control in the Eastern Mediterranean Region: progress in the implementation of the MPOWER measures.
El-Awa F; Bettcher D; Al-Lawati JA; Alebshehy R; Gouda H; Fraser CP
East Mediterr Health J; 2020 Jan; 26(1):102-109. PubMed ID: 32043552
[TBL] [Abstract][Full Text] [Related]
8. Tracking MPOWER in 14 countries: results from the Global Adult Tobacco Survey, 2008-2010.
Song Y; Zhao L; Palipudi KM; Asma S; Morton J; Talley B; Hsia J; Ramanandraibe N; Caixeta R; Fouad H; Khoury R; Sinha D; Rarick J; Bettcher D; Peruga A; Deland K; D'Espaignet ET;
Glob Health Promot; 2016 Jun; 23(2 Suppl):24-37. PubMed ID: 24042973
[TBL] [Abstract][Full Text] [Related]
9. MPOWER, needs and challenges: trends in the implementation of the WHO FCTC in the Eastern Mediterranean Region.
Heydari G; Zaatari G; Al-Lawati JA; El-Awa F; Fouad H
East Mediterr Health J; 2018 Apr; 24(1):63-71. PubMed ID: 29658622
[TBL] [Abstract][Full Text] [Related]
10. Tobacco prevention policies in west-African countries and their effects on smoking prevalence.
Winkler V; Lan Y; Becher H
BMC Public Health; 2015 Dec; 15():1216. PubMed ID: 26646580
[TBL] [Abstract][Full Text] [Related]
11. Implementation of MPOWER Package in the South-East Asia Region: Evidence from the WHO Report on the Global Tobacco Epidemic (2009-2021).
Kaur J; Rinkoo AV; Gouda HN; Prasad V; Pendse RN
Asian Pac J Cancer Prev; 2021 Nov; 22(S2):71-80. PubMed ID: 34780141
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008-2017.
Husain MJ; Datta BK; Nargis N; Iglesias R; Perucic AM; Ahluwalia IB; Tripp A; Fatehin S; Husain MM; Kostova D; Richter P
Tob Control; 2021 Nov; 30(6):630-637. PubMed ID: 32893187
[TBL] [Abstract][Full Text] [Related]
13. Impact of nations meeting the MPOWER targets between 2014 and 2016: an update.
Levy DT; Li Y; Yuan Z
Tob Control; 2020 Mar; 29(2):231-233. PubMed ID: 31053650
[TBL] [Abstract][Full Text] [Related]
14. The effect of MPOWER scores on cigarette smoking prevalence and consumption.
Ngo A; Cheng KW; Chaloupka FJ; Shang C
Prev Med; 2017 Dec; 105S():S10-S14. PubMed ID: 28502576
[TBL] [Abstract][Full Text] [Related]
15. Tobacco epidemic in Jordan: the time to act is now.
Al-Tammemi AB
Glob Health Promot; 2022 Jun; 29(2):97-101. PubMed ID: 34269113
[TBL] [Abstract][Full Text] [Related]
16. The association between MPOWER tobacco control policies and adolescent smoking across 36 countries: An ecological study over time (2006-2014).
de Looze ME; Henking C; Torsheim T; Currie DB; Weber MW; Alemán-Díaz AY
Int J Drug Policy; 2022 Nov; 109():103871. PubMed ID: 36202040
[TBL] [Abstract][Full Text] [Related]
17. Investing in Tobacco Control: Twelve Years of MPOWER Measures and Progress in the Western Pacific Region.
De Pinho Campos K; Kashiwabara M; Teakle A; De Guzman R; Lannan K; Mercado S
Asian Pac J Cancer Prev; 2020 Jul; 21(S1):9-16. PubMed ID: 32649165
[TBL] [Abstract][Full Text] [Related]
18. Tobacco Advertising, Promotion and Sponsorship in India and Indonesia: Present Regime and the Way Forward.
Chandra S; Rinkoo AV; Kaur J; Prasad V
Asian Pac J Cancer Prev; 2021 Nov; 22(S2):89-96. PubMed ID: 34780143
[TBL] [Abstract][Full Text] [Related]
19. Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control.
Fooks GJ; Smith J; Lee K; Holden C
Global Health; 2017 Mar; 13(1):12. PubMed ID: 28274267
[TBL] [Abstract][Full Text] [Related]
20. Framework Convention on Tobacco Control 2030-A Program to Accelerate the Implementation of World Health Organization Framework Convention for Tobacco Control in Low- and Middle-Income Countries: A Mixed-Methods Evaluation.
Siddiqi K; Elsey H; Khokhar MA; Marshall AM; Pokhrel S; Arora M; Crankson S; Mehra R; Morello P; Collin J; Fong GT
Nicotine Tob Res; 2023 May; 25(6):1074-1081. PubMed ID: 36757326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
